Cargando…

Effects of Cancer Presence and Therapy on the Platelet Proteome

Platelets are involved in tumor angiogenesis and cancer progression. Previous studies indicated that cancer could affect platelet content. In the current study, we investigated whether cancer-associated proteins can be discerned in the platelets of cancer patients, and whether antitumor treatment ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walraven, Maudy, Sabrkhany, Siamack, Knol, Jaco C., Dekker, Henk, de Reus, Inge, Piersma, Sander R., Pham, Thang V., Griffioen, Arjan W., Broxterman, Henk J., Oude Egbrink, Mirjam, Verheul, Henk M. W., Jimenez, Connie R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347210/ https://www.ncbi.nlm.nih.gov/pubmed/34361002 http://dx.doi.org/10.3390/ijms22158236

Ejemplares similares

Platelets as messengers of early-stage cancer
por: Sabrkhany, Siamack, et al.
Publicado: (2021)

Age- and gender-matched controls needed for platelet-based biomarker studies
por: Sabrkhany, Siamack, et al.
Publicado: (2022)

Peptide-mediated ‘miniprep’ isolation of extracellular vesicles is suitable for high-throughput proteomics
por: Knol, Jaco C., et al.
Publicado: (2016)

A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer
por: Wentink, Madelon Q, et al.
Publicado: (2016)

Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients
por: Tullemans, Bibian M. E., et al.
Publicado: (2018)

Advancing wide implementation of precision oncology: A liquid nitrogen‐free snap freezer preserves molecular profiles of biological samples
por: van der Wijngaart, Hanneke, et al.
Publicado: (2023)

Proteomic Analysis of miR-195 and miR-497 Replacement Reveals Potential Candidates that Increase Sensitivity to Oxaliplatin in MSI/P53wt Colorectal Cancer Cells
por: Poel, Dennis, et al.
Publicado: (2019)

Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature
por: Gotink, Kristy J., et al.
Publicado: (2014)

Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics
por: van der Wijngaart, Hanneke, et al.
Publicado: (2023)

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer
por: van der Mijn, Johannes C., et al.
Publicado: (2014)

Whole gel processing procedure for GeLC-MS/MS based proteomics
por: Piersma, Sander R, et al.
Publicado: (2013)

The Analysis of Platelet-Derived circRNA Repertoire as Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer
por: D’Ambrosi, Silvia, et al.
Publicado: (2021)

Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome
por: Labots, Mariette, et al.
Publicado: (2020)

Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2022)

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
por: Labots, Mariette, et al.
Publicado: (2016)

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
por: Gotink, Kristy J., et al.
Publicado: (2015)

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
por: Walraven, Maudy, et al.
Publicado: (2018)

INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
por: Beekhof, Robin, et al.
Publicado: (2019)

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2016)

Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth
por: Rovithi, Maria, et al.
Publicado: (2016)

Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture
por: Rajcevic, Uros, et al.
Publicado: (2014)

Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: a platform for drug testing
por: Rovithi, Maria, et al.
Publicado: (2017)

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
por: Labots, Mariette, et al.
Publicado: (2018)

Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management
por: Antunes-Ferreira, Mafalda, et al.
Publicado: (2023)

In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival
por: Said, Ibrahim, et al.
Publicado: (2022)

Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment
por: Schuurhuizen, Claudia S. E. W., et al.
Publicado: (2019)

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies
por: Goedegebuure, Ruben S.A., et al.
Publicado: (2020)

Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction
por: Kleibeuker, Esther A, et al.
Publicado: (2015)

Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling
por: Voortman, Johannes, et al.
Publicado: (2009)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Cancer cells copy migratory behavior and exchange signaling networks via extracellular vesicles
por: Steenbeek, Sander C, et al.
Publicado: (2018)

Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients
por: Buffart, Tineke E., et al.
Publicado: (2021)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
por: Rovithi, Maria, et al.
Publicado: (2017)

Hypoxia Impairs Initial Outgrowth of Endothelial Colony Forming Cells and Reduces Their Proliferative and Sprouting Potential
por: Tasev, Dimitar, et al.
Publicado: (2018)

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
por: Gotink, Kristy J., et al.
Publicado: (2009)

Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review
por: Walraven, Maudy, et al.
Publicado: (2010)

Increasing value in research: cost evaluations in health professions education
por: Schreurs, Sanne, et al.
Publicado: (2019)

The Potential Role of Lysosomal Sequestration in Sunitinib Resistance of Renal Cell Cancer
por: Azijli, Kaamar, et al.
Publicado: (2015)

The predictive value of cumulative toxicity for quality of life in patients with metastatic colorectal cancer during first-line palliative chemotherapy
por: Schuurhuizen, Claudia SEW, et al.
Publicado: (2018)

Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression
por: López González, Marta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_to3ksl90as0aqift7v64eocuvh